Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
for cancer treatment. Your Tasks: Research directions may include, but are not limited to: Investigation of molecular and cellular mechanisms of tumor response to interventional therapies, including
-
Master’s degree and PhD in Physics or a similar field, ideally with a specialization in quantum many-body physics Coursework and experience in (a subset of) quantum mechanics, condensed matter physics
-
researcher (m/f/d) (biology, biochemistry, biotechnology or related areas) Our project investigates the mechanisms of inherited bone marrow failure and its progression into hematological malignancies. Our
-
, molecular biotechnology and computational sciences. The modern Campus harbors the buildings of the science faculties and institutes, in direct vicinity to the University Hospital Heidelberg, the Max Planck
-
on the identification of novel cancer-promoting mechanisms in the tumor microenvironment. Based on these functional insights we aim to derive novel targets for therapeutic intervention. Translation of research findings
-
, molecular biotechnology and computational sciences. The modern Campus harbors the buildings of the science faculties and institutes, in direct vicinity to the University Hospital Heidelberg, the Max Planck
-
, molecular biotechnology and computational sciences. The modern Campus harbors the buildings of the science faculties and institutes, in direct vicinity to the University Hospital Heidelberg, the Max Planck
-
04.04.2025, Wissenschaftliches Personal The Chair for Computer Architecture and Parallel Systems (CAPS) offers this position as part of the DARE-project funded by the EuroHPC JU bringing together
-
, soft/condensed matter theory or continuum mechanics of fluids or solids? The Max Planck Institute for the Physics of Complex Systems (MPI‑PKS) in Dresden announces the opening of several postdoctoral
-
prescise molecular mechanisms underlying the tumorigenic effects of mutant IDH1 remain elusive. The successful candidate will use established in vitro and in vivo models of mutant IDH1 to assess the early